NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering - Royal DSM announces it has reached an agreement to acquire Prodap to drive efficiency and sustainability in animal farming - Prodap.com.br / DSM.com
DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering

 

NewswireTODAY - /newswire/ - Heerlen, Netherlands, 2022/06/07 - Royal DSM announces it has reached an agreement to acquire Prodap to drive efficiency and sustainability in animal farming - Prodap.com.br / DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Royal DSM, a global purpose-led science-based company, announces it has reached an agreement to acquire Prodap, a Brazilian animal nutrition and technology company that combines technology offerings, consulting services, and customized nutritional solutions to drive efficiency and sustainability in animal farming.

Precision farming is growing rapidly, driven by the increasing demand for sustainability, efficiency, traceability, and animal welfare in food systems under pressure to provide the world’s rising population with animal protein. DSM’s precision nutrition solutions for animal nutrition and health include Verax™, a unique and innovative integrated animal management system that leverages data to provide a deeper understanding of the health, productivity, and welfare of animals, and Sustell™, an intelligent sustainability service designed to enhance the environmental sustainability of animal protein production.

Based in Belo-Horizonte, Prodap (prodap.com.br) is at the forefront of the market for digital solutions, which is growing particularly quickly in Brazil. Prodap combines nutrition, consultancy, and technology services to optimize ruminant farming operations. Through its portfolio of digital solutions, it collects data and develops insights in real time, which are then translated into tailored nutritional solutions for customers, with remote or in-person support provided by its experienced consultants. Prodap has operations in the states of Mato Grosso and Minas Gerais and employs 330 employees, serving more than 5,000 farms across Brazil with impressive customer loyalty rates.

By harnessing the power of Prodap’s digital solutions, DSM will take another step forward in its Precision & Personalization journey. DSM will strengthen and further develop its digital solutions to reach more markets globally and species, enabling smarter nutritional decision-making thanks to artificial intelligence and other tools. Prodap will complement DSM’s deep animal nutrition knowledge and advisory capabilities with its extensive consultancy experience, facilitating an even higher level of customer experience. Additionally, by supporting more efficient farming, the acquisition contributes to DSM’s commitment to enabling a double-digit reduction in on-farm livestock emissions by 2030 as part of its 2021 food system commitments.

Ivo Lansbergen, EVP DSM Animal Nutrition & Health, commented: “The need for sustainable animal farming has never been greater or more urgent. Precision nutrition is a key pathway to improving the efficiency and sustainability of animal farming, creating value for a range of stakeholders, including farmers and society at large. As such, I’m delighted that we’re joining forces with Prodap to deliver precision farming solutions to our customers, which will contribute to more sustainable animal farming for all. Together, we make it possible!”

Leonardo Sá, CEO Prodap, said: “We are delighted to have found a company like DSM that sincerely shares our purpose on transforming the livestock worldwide and vision of adopting the new technologies essential to achieving sustainable and efficient farming. We look forward to accelerating the expansion of these new technologies in the industry, together with DSM.”

The transaction, which remains subject to customary conditions, is expected to close in 2022.

Contacts
Dave Huizing - DSM Investor Relations
P: +31 45 578 2864 - E: investor.relations[.]dsm.com.

Cristina Cassis - DSM Media Relations LATAM
P: +55 11 991 213941 - E: cristina.cassis[.]dsm.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Animal Nutrition | Royal DSM
Contact: Mirelle van der Kreeft - DSM.com 
+31 45 578 2420 media.contacts[.]dsm.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit BizJobs.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)